NCT01604772 2019-05-01Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst CarcinomaNational Cancer Institute (NCI)Phase 2 Completed16 enrolled 7 charts